Target intelligence / Profile preview

Exosomal microRNA signaling pathway (null)

Target
null
Molecular classification
Other, Non-coding RNA, Extracellular vesicle component, Intercellular messenger
01

Overview

Exosomal microRNA signaling refers to the process wherein microRNAs are selectively packaged into exosomes—small, membrane-bound extracellular vesicles—that are secreted from donor cells and taken up by recipient cells. These exosomal miRNAs act as potent regulators of gene expression, modulating cellular processes such as proliferation, differentiation, apoptosis, and immune activation by targeting mRNA molecules post-transcriptionally in recipient cells. This mechanism facilitates long-range intercellular communication, influencing tissue homeostasis, inflammation, regeneration, and pathology, notably in cancer progression and cardiovascular disease. Therapeutically, exosomal miRNAs are attractive both as disease biomarkers and as vehicles for drug delivery, but their complex biological roles and challenges in targeting specificity remain active areas of investigation.

Other names
Exosomal miRNA pathwaymicroRNA-mediated exosome signalingexosome-associated microRNA signaling
02

Mechanism of action

Inhibition of exosome secretion (e.g., GW4869 inhibits sphingomyelinase to block miRNA packaging into exosomes); Modulation of exosomal miRNA levels (e.g., miRNA mimics or antagomirs); Engineered exosome delivery of miRNAs or drugs (targeting cancer cells, modulating immune response).

03

Biological functions

Signal transductionIntercellular communicationGene expression regulation (post-transcriptional)Cell proliferationCell differentiationApoptosisImmune modulationTissue remodelingAngiogenesisInflammatory response
04

Disease associations

CancerCardiovascular diseaseInflammationNeurodegenerative diseaseInfectionOther (wound healing, fibrosis, metabolic bone disease)
05

Safety considerations

Immunogenicity of engineered exosomesUnintended effects of miRNA modulation on off-target gene pathwaysDifficulty in targeting exosomes specifically to desired recipient cellsLong-term effects of manipulating intercellular communication not fully understoodRisk of promoting metastasis or tumor growth if not precisely controlled
06

Interacting drugs

engineered exosomes

3 more in the full profile.

07

Biomarkers

Exosomal miRNA levels (e.g., miR-21-3p, miR-29 family, miR-106a-3p, miR-142-3p, miR-223, Let-7i)Exosome cargo screening in blood/biological fluids

Beyond the preview

Go deeper on Exosomal microRNA signaling pathway (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Exosomal microRNA signaling pathway (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call